Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines

被引：53

作者：

Wierda, William G. ^{[1
]}

Brown, Jennifer ^{[2
]}

Abramson, Jeremy S. ^{[3
]}

Awan, Farrukh ^{[4
]}

Bilgrami, Syed F. ^{[5
]}

Bociek, Greg ^{[6
]}

Brander, Danielle ^{[7
]}

Chanan-Khan, Asher A. ^{[8
]}

Coutre, Steve E. ^{[9
]}

Davis, Randall S. ^{[10
]}

Eradat, Herbert ^{[11
]}

Fletcher, Christopher D. ^{[12
]}

Gaballa, Sameh ^{[13
]}

Ghobadi, Armin ^{[14
,15
]}

Hamid, Muhammad Saad ^{[16
]}

Hernandez-Ilizaliturri, Francisco ^{[17
]}

Hill, Brian ^{[18
,19
]}

Kaesberg, Paul ^{[20
]}

Kamdar, Manali ^{[21
]}

Kaplan, Lawrence D. ^{[22
]}

Khan, Nadia ^{[23
]}

Kipps, Thomas J. ^{[24
]}

Ma, Shuo ^{[25
]}

Mato, Anthony ^{[26
]}

Mosse, Claudio ^{[27
]}

Schuster, Stephen ^{[28
]}

Siddiqi, Tanya ^{[29
]}

Stephens, Deborah M. ^{[30
]}

Ujjani, Chaitra ^{[31
]}

Wagner-Johnston, Nina ^{[32
]}

Woyach, Jennifer A. ^{[33
]}

Ye, J. Christine ^{[34
]}

Dwyer, Mary A. ^{[35
]}

Sundar, Hema ^{[35
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[5] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[7] Duke Canc Inst, Durham, NC USA

[8] Mayo Clin, Canc Ctr, Rochester, MN USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA

[11] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[12] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[15] Washington Univ, Sch Med, St Louis, MO USA

[16] Univ Tennessee, Hlth Sci Ctr, St Jude Chidrens Res Hosp, Knoxville, TN 37996 USA

[17] Roswel Pk Comprehens Canc Ctr, Buffalo, NY USA

[18] Univ Hosp Seidman Canc Ctr, Case Comprehensve Canc Ctr, Cleveland, OH USA

[19] Cleveland Clin, Tausslg Canc Inst, Cleveland, OH 44106 USA

[20] UC Davis Comprehens Canc Ctr, Davis, CA USA

[21] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[22] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[23] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[24] UC San Diego Moores Canc Ctr, San Diego, CA USA

[25] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[26] Mem Sloan Kettering Canc Ctr, Ithaca, NY USA

[27] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[28] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[29] City Hope Natl Med Ctr, Duarte, CA USA

[30] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[31] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[32] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[33] Ohio State Univ, Comprehenslve Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[34] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[35] Natl Comprehens Canc Network, Philadelphia, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 06期

关键词：

MINIMAL RESIDUAL DISEASE; CHLORAMBUCIL PLUS OBINUTUZUMAB; FLOW-CYTOMETRY; OPEN-LABEL; 1ST-LINE TREATMENT; FOLLOW-UP; PHASE-II; IBRUTINIB; VENETOCLAX; CLL;

D O I：

10.6004/jnccn.2022.0031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton???s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective chemotherapy-free option for patients with previously untreated or relapsed/refractory CLL/SLL. Undetectable minimal residual disease after the end of treatment is emerging as an important predictor of progression-free and overall survival for patients treated with fixed-duration BCL-2 inhibitor-based treatment. These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/ SLL specific to the use of chemotherapy-free treatment options for patients with treatment-na??ve and relapsed/refractory disease.

引用

页码：622 / 634

页数：13

共 50 条

[1] NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
Wierda, William G.
Zelenetz, Andrew D.
Gordon, Leo I.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Caimi, Paolo
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Hoppe, Richard T.
Horwitz, Steven M.
Kaminski, Mark S.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Martin, Michael G.
Nademanee, Auayporn
Porcu, Pierluigi
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth
Saad, Ayman A.
Snyder, Erin D.
Sokol, Lubomir
Swinnen, Lode J.
Vose, Julie M.
Yahalom, Joachim
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 293 - 311
[2] NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 (vol 20, pg 622, 2022)
Wierda, William G.
Brown, Jennifer
Abramson, Jeremy S.
Awan, Farrukh
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Chanan-Khan, Asher A.
Coutre, Steve E.
Davis, Randall S.
Eradat, Herbert
Fletcher, Christopher D.
Gaballa, Sameh
Ghobadi, Armin
Muhammad, Saad Hamid
Hernandez-Ilizaliturri, Francisco
Hill, Brian
Kaesberg, Paul
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Ma, Shuo
Mato, Anthony
Mosse, Claudio
Schuster, Stephen
Siddiqi, Tanya
Stephens, Deborah M.
Ujjani, Chaitra
Wagner-Johnston, Nina
Woyach, Jennifer A.
Ye, J. Christine
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (07): : XXIV - XXIV
[3] NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019
Wierda, William G.
Byrd, John C.
Abramson, Jeremy S.
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Brown, Jennifer
Chanan-Khan, Asher A.
Chavez, Julio C.
Coutre, Steve E.
Davis, Randall S.
Fletcher, Christopher D.
Hill, Brian
Kahl, Brad S.
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Ma, Shuo
Malek, Sami
Mato, Anthony
Mosse, Claudio
Neppalli, Vishala T.
Shadman, Mazyar
Siddiqi, Tanya
Stephens, Deborah
Wagner, Nina
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 12 - 20
[4] NCCN Guidelines Update: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Stephens, Deborah M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 563 - 566
[5] Multiple Myeloma, Version 3.2022 Featured Updates to the NCCN Guidelines
Callander, Natalie S.
Baljevic, Muhamed
Adekola, Kehinde
Anderson, Larry D.
Campagnaro, Erica
Castillo, Jorge J.
Costello, Caitlin
Devarakonda, Srinivas
Elsedawy, Noura
Faiman, Matthew
Garfall, Alfred
Godby, Kelly
Hillengass, Jens
Holmberg, Leona
Htut, Myo
Huff, Carol Ann
Hultcrantz, Malin
Kang, Yubin
Larson, Sarah
Liedtke, Michaela
Martin, Thomas
Omel, James
Sborov, Douglas
Shain, Kenneth
Stockerl-Goldstein, Keith
Weber, Donna
Berardi, Ryan A.
Kumar, Rashmi
Kumar, Shaji K.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (01): : 9 - 19
[6] Myelodysplastic Syndromes, Version 3.2022 Featured Updates to the NCCN Guidelines
Greenberg, Peter L.
Stone, Richard M.
Al-Kali, Aref
Bennett, John M.
Borate, Uma
Brunner, Andrew M.
Chai-Ho, Wanxing
Curtin, Peter
de Castro, Carlos M.
Deeg, H. Joachim
DeZern, Amy E.
Dinner, Shira
Foucar, Charles
Gaensler, Karin
Garcia-Manero, Guillermo
Griffiths, Elizabeth A.
Head, David
Jonas, Brian A.
Keel, Sioban
Madanat, Yazan
Maness, Lori J.
Mangan, James
McCurdy, Shannon
McMahon, Christine
Patel, Bhumika
Reddy, Vishnu V.
Sallman, David A.
Shallis, Rory
Shami, Paul J.
Thota, Swapna
Varshavsky-Yanovsky, Asya Nina
Westervelt, Peter
Hollinger, Elizabeth
Shead, Dorothy A.
Hochstetler, Cindy
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 107 - 117
[7] Hematopoietic Cell Transplantation, Version 3.2022 Featured Updates to the NCCN Guidelines
Saad, Ayman
Loren, Alison
Bolanos-Meade, Javier
Chen, George
Couriel, Daniel
Di Stasi, Antonio
El-Jawahri, Areej
Elmariah, Hany
Farag, Sherif
Gundabolu, Krishna
Gutman, Jonathan
Ho, Vincent
Hoeg, Rasmus
Horwitz, Mitchell
Hsu, Joe
Kassim, Adetola
Dabaja, Mohamed Kharfan
Magenau, John
Martin, Thomas
Mielcarek, Marco
Moreira, Jonathan
Nakamura, Ryotaro
Nieto, Yago
Ninos, Cameron
Oliai, Caspian
Patel, Seema
Randolph, Brion
Schroeder, Mark
Tzachanis, Dimitrios
Varshavsky-Yanovsky, Asya Nina
Vusirikala, Madhuri
Algieri, Frankie
Pluchino, Lenora A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (02): : 108 - 115
[8] Interpretation of NCCN Guideline: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Version 1, 2017)
Xia Lei
Tang Yan
Xu Xin-yu
Zhu Miao-lin
JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2016, 4 (04): : 287 - 292
[9] NCCN Guidelines® Insights Chronic Myeloid Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
Pallera, Arnel
Altman, Jessica K.
Berman, Ellin
Abboud, Camille N.
Bhatnagar, Bhavana
Curtin, Peter
DeAngelo, Daniel J.
Gotlib, Jason
Hagelstrom, R. Tanner
Hobbs, Gabriela
Jagasia, Madan
Kantarjian, Hagop M.
Kropf, Patricia
Metheny, Leland
Moore, Joseph O.
Ontiveros, Evelena
Purev, Enkhtsetseg
Quiery, Albert
Reddy, Vishnu V. B.
Rose, Michal G.
Shah, Neil P.
Smith, B. Douglas
Snyder, David S.
Sweet, Kendra L.
Tibes, Raoul
Yang, David T.
Gregory, Kristina
Sundar, Hema
Deininger, Michael
Radich, Jerald P.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (12): : 1505 - 1512
[10] Chronic Myelogenous Leukemia, Version 1.2014 Featured Updates to the NCCN Guidelines
O'Brien, Susan
Radich, Jerald P.
Abboud, Camille N.
Akhtari, Mojtaba
Altman, Jessica K.
Berman, Ellin
DeAngelo, Daniel J.
Deininger, Michael
Devine, Steven
Fathi, Amir T.
Gotlib, Jason
Jagasia, Madan
Kropf, Patricia
Moore, Joseph O.
Pallera, Arnel
Pinilla-Ibarz, Javier
Reddy, Vishnu Vb.
Shah, Neil P.
Smith, B. Douglas
Snyder, David S.
Wetzler, Meir
Gregory, Kristina
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (11): : 1327 - 1340

← 1 2 3 4 5 →